首页> 外文OA文献 >6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer

【2h】

6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer

机译：6-取代的六亚甲基氨基硼（HMA）衍生物作为人尿激酶纤溶酶原激活剂的有效和选择性抑制剂，用于癌症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Benjamin J. Buckley; Ashraf Aboelela; Elahe Minaei; Longguang X. Jiang; Zhihong Xu; Umar Ali; Karen Fildes; Chen-Yi Cheung; Simon M. Cook; Darren C. Johnson; Daniel A. Bachovchin; Gregory M. Cook; Minoti Apte; Mingdong Huang; Marie Ranson; Michael J. Kelso;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer [J] . Buckley Benjamin J., Aboelela Ashraf, Minaei Elahe, Journal of Medicinal Chemistry . 2018,第18期

机译：6-取代的六亚甲基氨基硼（HMA）衍生物作为人尿激酶纤溶酶原激活剂的有效和选择性抑制剂，用于癌症
2. Amiloride Analogues as Inhibitors of Human Urokinase Plasminogen Activator and Anti-Pancreatic Cancer Agents [J] . Xu Z., Buckley B. J., Pothula S., Pancreas . 2018,第10期

机译：Amiloride类似物作为人尿激酶纤溶酶原激活剂和抗胰腺癌剂的抑制剂
3. 4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors. [J] . Spencer JR, McGee D, Allen D, Bioorganic and Medicinal Chemistry Letters . 2002,第15期

机译：4-氨基芳基胍和4-氨基苯甲m衍生物作为有效的和选择性的尿激酶型纤溶酶原激活剂抑制剂。
4. Inhibition of the Tumor-Associated Urokinase-Type Plasminogen Activation System: Effects of High-Level Synthesis of Soluble Urokinase Receptor in Ovarian and Breast Cancer Cells In Vitro and In Vivo [C] . Viktor Magdolen International Meeting on Molecular Staging on Cancer . 2003

机译：抑制肿瘤相关的尿激酶型纤溶酶原激活系统：高水平合成在体外和体内卵巢癌细胞中可溶性尿激酶受体的影响
5. The role of urokinase plasminogen activator receptor in human pleural malignant mesothelioma [D] . Dean, Candice 2008

机译：尿激酶纤溶酶原激活物受体在人胸膜恶性间皮瘤中的作用
6. 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer [O] . Benjamin J. Buckley, Ashraf Aboelela, Elahe Minaei, -1

机译：6-取代的六亚甲基六胺（HMA）衍生物作为人类尿激酶纤溶酶原激活剂的强效和选择性抑制剂可用于癌症
7. Amiloride selectively inhibits the urokinase-type plasminogen activator [O] . Vassalli Jean-Dominique, Belin Dominique 1987

机译：阿米洛利选择性抑制尿激酶型纤溶酶原激活剂
8. Cellular Mechanisms Regulating Urokinase-Type Plasminogen Activator in Hormone Refractory Prostate Cancer: A Novel Therapeutic Target [R] . Gallick, G. E. 2004

机译：调节激素难治性前列腺癌中尿激酶型纤溶酶原激活物的细胞机制：一种新的治疗靶点

6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅